Furin-cleavage site is present in an antiparallel β-strand in SARS-CoV2 Spike protein
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Furin cleavage-site (CS) present between the S1/S2 junction in SARS-CoV2 spike (S) protein is critical to drive the fusion of SARS-CoV2 with the host cell. SARS-CoV2 falls in the sarbecovirus lineage that doesn’t comprise of furin CS and therefore makes its origin enigmatic. The available wild-type (Wt) SARS-CoV2 S protein with PDB ID: 6yvb lacks a stretch of amino acid including furin CS as well. All investigators till date have shown this stretch existing in the form of a loop. We are for the first time reporting that this stretch comprises of 14 amino acid residues (677QTNSPRRARSVASQ689), forming an antiparallel β-sheet comprising of PRRAR furin CS. We observed the presence of this antiparallel β-sheet in MERS spike protein as well. While switching over from Wt. SARS-CoV2 with PRRAR furin CS to B.1.1.7 variant with HRRAR furin CS, we found 3% increase in the percentage content of β stands. Interestingly, we found that the change of B.1.1.7 to B.1.617 variant comprising of RRRAR furin CS shifted the percentage secondary structure back to that found in Wt. SARS-CoV2. We anticipate that this β-sheet is used as a docking site by host cell proteases to act on furin-CS. Additionally, we studied the interaction of modeled SARS-CoV2 S protein with transmembrane protease, serine 2 (TMPRSS2), and furin proteases, which clearly highlighted that these proteases exclusively uses furin CS located in β-sheet to cleave the SARS-CoV2 S protein at its S1/S2 junction.
Article activity feed
-
-
-
SciScore for 10.1101/2022.02.18.481028: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Various SARS-CoV2 mutants such as SARS-CoV2 (K417N), SARS-CoV2 (E484K), SARS-CoV2 (N501Y), SARS-CoV2 (E484Q), SARS-CoV2 (L452R), SARS-CoV2 double-mutant (E484Q and L452R), SARS-CoV2 triple-mutant (K417N, E484K, and N501Y) were introduced in silico through PyMol software. PyMolsuggested: (PyMOL, RRID:SCR_000305)Electrostatic potential of wild-type SARS-CoV2 and its mutants were generated through PyMol software Protein◻Protein Protein◻Proteinsuggested: NoneResults from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the …SciScore for 10.1101/2022.02.18.481028: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Software and Algorithms Sentences Resources Various SARS-CoV2 mutants such as SARS-CoV2 (K417N), SARS-CoV2 (E484K), SARS-CoV2 (N501Y), SARS-CoV2 (E484Q), SARS-CoV2 (L452R), SARS-CoV2 double-mutant (E484Q and L452R), SARS-CoV2 triple-mutant (K417N, E484K, and N501Y) were introduced in silico through PyMol software. PyMolsuggested: (PyMOL, RRID:SCR_000305)Electrostatic potential of wild-type SARS-CoV2 and its mutants were generated through PyMol software Protein◻Protein Protein◻Proteinsuggested: NoneResults from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: We found the following clinical trial numbers in your paper:
Identifier Status Title NCT04348396 Recruiting Clinical and Biological Predictors of COVID-19 Disease in Ol… NCT04366089 Recruiting Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID… Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on page 15. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-